Neurotrope (NTRP) ROE US GAAP (year values) |
|||||||||
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -57.4% | -99.2% | 0.00% | -137.4% | -276.2% | -242.7% | ||
| Changes by years, y/y, % | +43pp | -42pp | +99pp | -139pp | +22.4% | ||||
Neurotrope. ROE, %
Neurotrope. ROE, changes, pp
Neurotrope (NTRP) ROE US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | FY2026Q4 | LTM ? | |||
| ROE, % | ? | -137.4% | -188.9% | -233.5% | -242.7% | -276.2% | -242.7% | |
| Changes by years, y/y, % | +164pp | -958pp | -139pp | |||||
| Changes by quarters, q/q, % | -852pp | -51pp | -45pp | -9pp | -34pp | |||